MAPT and Alzheimer disease: In addition to the analyses within specific groups (NC or MCI as diagnosed at baseline), we also found significant associations between AD-RAI and well-established AD biomarkers [25] at baseline (such as Aβ quantified from CSF or F18-AV-45 PET and tau from CSF) in the entire cohort (Table 2).